Maithili Life Sciences to Exhibit at CPHI Milan 2024
After successful participation at Pharmaconex Egypt, FCE Pharma Brazil, and CPHI Korea, Maithili Life Sciences is excited to announce our upcoming exhibition at the prestigious CPHI Milan 2024, from October 08th to 10th. This event is a major global platform for pharmaceutical professionals, and we are thrilled to be part of it, showcasing our extensive range of high-quality Active Pharmaceutical Ingredients (APIs) and intermediates.
Why CPHI Milan is Important
CPHI Milan is one of the most influential events in the pharmaceutical industry, attracting top companies, researchers, and decision-makers from around the globe. It provides a perfect opportunity for networking, knowledge sharing, and forging valuable partnerships with key stakeholders in the pharmaceutical supply chain. Our participation solidifies our commitment to expanding our footprint in the European market and highlights our dedication to providing superior quality APIs.
Why Maithili Life Sciences is a Leading Supplier in Europe
- High-Quality APIs:
We are recognized for delivering APIs that meet stringent European regulatory standards such as EU-GMP, ensuring safety, reliability, and efficacy. - Diverse Product Portfolio:
Our offerings span across multiple therapeutic categories, addressing the varied needs of the European market. - Innovative R&D:
Our dedicated R&D team is continually developing new and improved APIs, ensuring we stay ahead of market demands. - Regulatory Compliance:
All our products comply with international regulatory frameworks, making us a trusted partner for pharmaceutical companies across Europe.
Our Extensive API and Intermediates Product Range
Our portfolio includes a wide range of APIs and intermediates, serving various therapeutic segments:
- Azilsartan Medoxomil Potassium Salt: An angiotensin II receptor antagonist used to treat high blood pressure.
- Benazepril HCl: An ACE inhibitor for treating hypertension.
- Irbesartan: Used to treat high blood pressure and diabetic nephropathy.
- Nebivolol HCl: A beta-blocker that treats high blood pressure.
- Telmisartan: An angiotensin receptor blocker (ARB) for managing hypertension.
- Brivaracetam: Used as an anticonvulsant for epilepsy.
- Modafinil: Promotes wakefulness in conditions like narcolepsy.
- Rasagiline Mesylate: Used in the treatment of Parkinson’s disease.
- Trazodone: An antidepressant used for major depressive disorder.
- Ornidazole: An antibiotic used to treat infections caused by anaerobic bacteria and protozoa.
- Favipiravir: An antiviral used to treat influenza and COVID-19.
- Voriconazole: An antifungal medication for serious fungal infections.
- Etoricoxib: A COX-2 inhibitor for osteoarthritis and rheumatoid arthritis.
- Zaltoprofen: A non-steroidal anti-inflammatory drug (NSAID).
- Cabergoline Intermediates: Used in the treatment of hyperprolactinemia and pituitary tumors.
- Dabigatran Etexilate Mesylate: An anticoagulant used to prevent strokes and blood clots.
- Darolutamide Intermediates: Used in the treatment of non-metastatic castration-resistant prostate cancer.
- Minoxidil: Primarily used for its ability to promote hair growth.
- Dapoxetine HCl: Used for treating premature ejaculation.
- Solifenacin Succinate: Used to treat overactive bladder.
- Sumatriptan Succinate: For the treatment of migraine headaches.
- Tadalafil: Used to treat erectile dysfunction and benign prostatic hyperplasia.
- Tamsulosin: Treats benign prostatic hyperplasia.
- Ticagrelor: An antiplatelet medication to reduce cardiovascular events.
- Torsemide: A diuretic for treating edema and hypertension.
- Sildenafil: Treats erectile dysfunction and pulmonary arterial hypertension.
- Vardenafil: Used to treat erectile dysfunction.
Leading the Way in European API Supply
Our participation in CPHI Milan marks a significant step in our journey to becoming the go-to API supplier in Europe. Our focus is not just on meeting the regulatory standards but also on exceeding expectations in product quality and service. We are actively seeking partnerships with European pharmaceutical companies to provide innovative, cost-effective, and high-quality APIs that help bring essential medications to market.
Visit Us at CPHI Milan 2024
We invite you to visit us at Booth 1F72 in the API Zone during CPHI Milan 2024. Our team will be present to discuss how Maithili Life Sciences can fulfill your API and intermediate needs and explore potential collaborations to bring innovative pharmaceutical solutions to the European market.
Contact Us
For more information about Maithili Life Sciences and our extensive range of APIs and intermediates, please contact us at [email protected] or visit our website www.maithililifesciences.com.
Maithili Life Sciences: Your Trusted API Partner in Europe